These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22238388)

  • 1. Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study.
    Olson NC; Callas PW; Hanley AJ; Festa A; Haffner SM; Wagenknecht LE; Tracy RP
    J Clin Endocrinol Metab; 2012 Mar; 97(3):1032-40. PubMed ID: 22238388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
    Karter AJ; Mayer-Davis EJ; Selby JV; D'Agostino RB; Haffner SM; Sholinsky P; Bergman R; Saad MF; Hamman RF
    Diabetes; 1996 Nov; 45(11):1547-55. PubMed ID: 8866560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
    Haffner SM; Howard G; Mayer E; Bergman RN; Savage PJ; Rewers M; Mykkänen L; Karter AJ; Hamman R; Saad MF
    Diabetes; 1997 Jan; 46(1):63-9. PubMed ID: 8971083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.
    Haffner SM; D'Agostino R; Saad MF; Rewers M; Mykkänen L; Selby J; Howard G; Savage PJ; Hamman RF; Wagenknecht LE
    Diabetes; 1996 Jun; 45(6):742-8. PubMed ID: 8635647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone.
    Osei K; Gaillard T; Schuster D
    Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.
    Osei K; Schuster DP
    Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study.
    Lorenzo C; Wagenknecht LE; D'Agostino RB; Rewers MJ; Karter AJ; Haffner SM
    Diabetes Care; 2010 Jan; 33(1):67-72. PubMed ID: 19808919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis Study (IRAS).
    Mayer-Davis EJ; Levin S; Bergman RN; D'Agostino RB; Karter AJ; Saad MF;
    Diabetes Metab Res Rev; 2001; 17(2):137-45. PubMed ID: 11307179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.
    Haffner SM; D'Agostino R; Mykkänen L; Tracy R; Howard B; Rewers M; Selby J; Savage PJ; Saad MF
    Diabetes Care; 1999 Apr; 22(4):562-8. PubMed ID: 10189532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The homeostasis model in the San Antonio Heart Study.
    Haffner SM; Miettinen H; Stern MP
    Diabetes Care; 1997 Jul; 20(7):1087-92. PubMed ID: 9203442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
    Bell RA; Mayer-Davis EJ; Martin MA; D'Agostino RB; Haffner SM
    Diabetes Care; 2000 Nov; 23(11):1630-6. PubMed ID: 11092284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
    Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of insulin sensitivity, insulin secretion, and adiposity with insulin clearance in a multiethnic population: the insulin Resistance Atherosclerosis study.
    Lorenzo C; Hanley AJ; Wagenknecht LE; Rewers MJ; Stefanovski D; Goodarzi MO; Haffner SM
    Diabetes Care; 2013 Jan; 36(1):101-3. PubMed ID: 22933441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion.
    Pimenta WP; Santos ML; Cruz NS; Aragon FF; Padovani CR; Gerich JE
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):468-76. PubMed ID: 12522327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
    Bacha F; Gungor N; Lee S; Arslanian SA
    Diabetes Care; 2009 Jan; 32(1):100-5. PubMed ID: 18835946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
    Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
    Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
    Goff DC; D'Agostino RB; Haffner SM; Otvos JD
    Metabolism; 2005 Feb; 54(2):264-70. PubMed ID: 15690322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
    Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
    Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS).
    Lee CC; Watkins SM; Lorenzo C; Wagenknecht LE; Il'yasova D; Chen YD; Haffner SM; Hanley AJ
    Diabetes Care; 2016 Apr; 39(4):582-8. PubMed ID: 26895884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.